AFM and hepatocellular carcinoma: More specifically, the former constitutes a significant prognostic biomarker for HCC, being closely implicated with the HCC microenvironment, while it targets the afamin (AFM) gene, leading to tumor invasive behavior and metastatic dissemination [99].